ID   RHAS_ECOLI              Reviewed;         278 AA.
AC   P09377; Q2M8K2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   04-FEB-2015, entry version 144.
DE   RecName: Full=HTH-type transcriptional activator RhaS;
DE   AltName: Full=L-rhamnose operon regulatory protein RhaS;
GN   Name=rhaS; Synonyms=rhaC2; OrderedLocusNames=b3905, JW3876;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3316663; DOI=10.1016/0022-2836(87)90405-0;
RA   Tobin J.F., Schleif R.F.;
RT   "Positive regulation of the Escherichia coli L-rhamnose operon is
RT   mediated by the products of tandemly repeated regulatory genes.";
RL   J. Mol. Biol. 196:789-799(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the
RT   region from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   FUNCTION, AND INDUCTION.
RC   STRAIN=ECL116;
RX   PubMed=8230210; DOI=10.1006/jmbi.1993.1565;
RA   Egan S.M., Schleif R.F.;
RT   "A regulatory cascade in the induction of rhaBAD.";
RL   J. Mol. Biol. 234:87-98(1993).
RN   [6]
RP   FUNCTION.
RX   PubMed=8757746;
RA   Via P., Badia J., Baldoma L., Obradors N., Aguilar J.;
RT   "Transcriptional regulation of the Escherichia coli rhaT gene.";
RL   Microbiology 142:1833-1840(1996).
RN   [7]
RP   DNA-BINDING, AND MUTAGENESIS OF LEU-201; ARG-202; HIS-205; ARG-206;
RP   CYS-246; GLY-247; PHE-248; SER-249; ASP-250; SER-251; ASN-252;
RP   HIS-253; PHE-254; SER-255 AND THR-256.
RC   STRAIN=ECL116;
RX   PubMed=10464186;
RA   Bhende P.M., Egan S.M.;
RT   "Amino acid-DNA contacts by RhaS: an AraC family transcription
RT   activator.";
RL   J. Bacteriol. 181:5185-5192(1999).
RN   [8]
RP   INTERACTION WITH SIGMA-70.
RC   STRAIN=ECL116;
RX   PubMed=10940041; DOI=10.1128/JB.182.17.4959-4969.2000;
RA   Bhende P.M., Egan S.M.;
RT   "Genetic evidence that transcription activation by RhaS involves
RT   specific amino acid contacts with sigma 70.";
RL   J. Bacteriol. 182:4959-4969(2000).
RN   [9]
RP   REGULATION BY CRP.
RX   PubMed=11073923; DOI=10.1128/JB.182.23.6774-6782.2000;
RA   Holcroft C.C., Egan S.M.;
RT   "Interdependence of activation at rhaSR by cyclic AMP receptor
RT   protein, the RNA polymerase alpha subunit C-terminal domain, and
RT   rhaR.";
RL   J. Bacteriol. 182:6774-6782(2000).
RN   [10]
RP   INTERACTION WITH SIGMA-70.
RX   PubMed=15342598; DOI=10.1128/JB.186.18.6277-6285.2004;
RA   Wickstrum J.R., Egan S.M.;
RT   "Amino acid contacts between sigma 70 domain 4 and the transcription
RT   activators RhaS and RhaR.";
RL   J. Bacteriol. 186:6277-6285(2004).
CC   -!- FUNCTION: Activates expression of the rhaBAD and rhaT operons.
CC       {ECO:0000269|PubMed:8230210, ECO:0000269|PubMed:8757746}.
CC   -!- SUBUNIT: Binds DNA as a dimer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: Induced by RhaR in response to L-rhamnose. Binding of
CC       the cAMP receptor protein (CRP) is required for full expression.
CC       {ECO:0000269|PubMed:8230210}.
CC   -!- SIMILARITY: Contains 2 HTH araC/xylS-type DNA-binding domains.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06058; CAA29452.1; -; Genomic_DNA.
DR   EMBL; L19201; AAB03038.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76887.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77404.1; -; Genomic_DNA.
DR   PIR; S40849; S40849.
DR   RefSeq; NP_418341.1; NC_000913.3.
DR   RefSeq; YP_491545.1; NC_007779.1.
DR   ProteinModelPortal; P09377; -.
DR   SMR; P09377; 23-90, 169-273.
DR   DIP; DIP-10694N; -.
DR   IntAct; P09377; 24.
DR   MINT; MINT-1305270; -.
DR   STRING; 511145.b3905; -.
DR   EnsemblBacteria; AAC76887; AAC76887; b3905.
DR   EnsemblBacteria; BAE77404; BAE77404; BAE77404.
DR   GeneID; 12932004; -.
DR   GeneID; 948397; -.
DR   KEGG; ecj:Y75_p3281; -.
DR   KEGG; eco:b3905; -.
DR   PATRIC; 32123321; VBIEscCol129921_4021.
DR   EchoBASE; EB0836; -.
DR   EcoGene; EG10843; rhaS.
DR   eggNOG; COG2207; -.
DR   HOGENOM; HOG000290513; -.
DR   InParanoid; P09377; -.
DR   KO; K02855; -.
DR   OMA; YAIAIEP; -.
DR   OrthoDB; EOG66XBBN; -.
DR   PhylomeDB; P09377; -.
DR   BioCyc; EcoCyc:PD00221; -.
DR   BioCyc; ECOL316407:JW3876-MONOMER; -.
DR   PRO; PR:P09377; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   Genevestigator; P09377; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IMP:EcoCyc.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:EcoCyc.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:EcoCyc.
DR   GO; GO:0019299; P:rhamnose metabolic process; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.60; -; 2.
DR   Gene3D; 2.60.120.10; -; 1.
DR   HAMAP; MF_01534; HTH_type_RhaS; 1.
DR   InterPro; IPR003313; AraC-bd.
DR   InterPro; IPR009057; Homeodomain-like.
DR   InterPro; IPR018060; HTH_AraC.
DR   InterPro; IPR018062; HTH_AraC-typ_CS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR020449; Tscrpt_reg_HTH_AraC-type.
DR   InterPro; IPR023609; Tscrpt_reg_HTH_RhaS.
DR   Pfam; PF02311; AraC_binding; 1.
DR   Pfam; PF00165; HTH_AraC; 2.
DR   PRINTS; PR00032; HTHARAC.
DR   SMART; SM00342; HTH_ARAC; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   SUPFAM; SSF51215; SSF51215; 1.
DR   PROSITE; PS00041; HTH_ARAC_FAMILY_1; 1.
DR   PROSITE; PS01124; HTH_ARAC_FAMILY_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Cytoplasm; DNA-binding;
KW   Reference proteome; Repeat; Rhamnose metabolism; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    278       HTH-type transcriptional activator RhaS.
FT                                /FTId=PRO_0000194563.
FT   DNA_BIND    190    209       H-T-H motif. {ECO:0000250}.
FT   DNA_BIND    239    262       H-T-H motif. {ECO:0000250}.
FT   SITE        241    241       Interaction with sigma-70.
FT   SITE        250    250       Interaction with sigma-70.
FT   MUTAGEN     201    201       L->A: 48% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     202    202       R->A: 4% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     205    205       H->A: 28% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     206    206       R->A: 0.1% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     246    246       C->A: 66% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     247    247       G->A: 6.2% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     247    247       G->R: 0.9% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     248    248       F->A: 0.9% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     248    248       F->V: 3.3% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     249    249       S->G: 93% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     250    250       D->A: 8.3% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     251    251       S->G: 87% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     252    252       N->A: 31% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     252    252       N->H: 0.4% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     252    252       N->I: 0.3% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     252    252       N->S: 37% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     253    253       H->A: 48% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     253    253       H->Q: 32% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     254    254       F->A: 1.2% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     255    255       S->A: 80% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
FT   MUTAGEN     256    256       T->A: 61% of wild-type activity.
FT                                {ECO:0000269|PubMed:10464186}.
SQ   SEQUENCE   278 AA;  32315 MW;  64264514484C0D2A CRC64;
     MTVLHSVDFF PSGNASVAIE PRLPQADFPE HHHDFHEIVI VEHGTGIHVF NGQPYTITGG
     TVCFVRDHDR HLYEHTDNLC LTNVLYRSPD RFQFLAGLNQ LLPQELDGQY PSHWRVNHSV
     LQQVRQLVAQ MEQQEGENDL PSTASREILF MQLLLLLRKS SLQENLENSA SRLNLLLAWL
     EDHFADEVNW DAVADQFSLS LRTLHRQLKQ QTGLTPQRYL NRLRLMKARH LLRHSEASVT
     DIAYRCGFSD SNHFSTLFRR EFNWSPRDIR QGRDGFLQ
//
